» Articles » PMID: 28955335

Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition

Overview
Journal Front Immunol
Date 2017 Sep 29
PMID 28955335
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment determines development and progression of many cancers. Epithelial-mesenchymal transition (EMT) is fundamental to tumor progression and metastasis not only by increasing invasiveness but also by increasing resistance to cell death, senescence, and various cancer therapies; determining inflammation and immune surveillance; and conferring stem cell properties. It does this by enabling polarized epithelial cells to transform into cells with a mesenchymal, and therefore motile, phenotype. Tumor-associated macrophages (TAMs) are key cells of the tumor microenvironment that orchestrate the connection between inflammation and cancer. Activation of EMT often requires crosstalk between cancer cells and components of the local tumor microenvironment, including TAMs. In this review, clinical and experimental evidence is presented for control of TAMs in promoting cancer cell invasion and migration and their interaction with the EMT process in the metastatic cascade. The translational significance of these findings is that the signaling pathways that interconnect TAMs and EMT-modified cancer cells may represent promising therapeutic targets for the treatment of tumor metastasis.

Citing Articles

The role of macrophages in liver metastasis: mechanisms and therapeutic prospects.

Yuan Q, Jia L, Yang J, Li W Front Immunol. 2025; 16:1542197.

PMID: 40034694 PMC: 11872939. DOI: 10.3389/fimmu.2025.1542197.


ANKRD22 participates in the proinflammatory activities of macrophages in the colon cancer tumor microenvironment.

Wang X, Yang K, Yang B, Wang R, Zhu Y, Pan T Cancer Immunol Immunother. 2025; 74(3):86.

PMID: 39891675 PMC: 11787111. DOI: 10.1007/s00262-024-03930-z.


Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma.

Liu Z, Yang X, Chen S, Jia W, Qian Y, Zhang M Sci Rep. 2024; 14(1):28039.

PMID: 39543336 PMC: 11564793. DOI: 10.1038/s41598-024-78663-1.


A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells.

Zhao X, Ren T, Li S, Wang X, Hou R, Guan Z Int J Biol Sci. 2024; 20(13):5109-5126.

PMID: 39430253 PMC: 11489172. DOI: 10.7150/ijbs.99680.


The complexity of immune evasion mechanisms throughout the metastatic cascade.

Haynes N, Chadwick T, Parker B Nat Immunol. 2024; 25(10):1793-1808.

PMID: 39285252 DOI: 10.1038/s41590-024-01960-4.


References
1.
Joyce J, Pollard J . Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009; 9(4):239-52. PMC: 3251309. DOI: 10.1038/nrc2618. View

2.
Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

3.
Zhang Q, Liu L, Gong C, Shi H, Zeng Y, Wang X . Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One. 2013; 7(12):e50946. PMC: 3532403. DOI: 10.1371/journal.pone.0050946. View

4.
Yuan Z, Luo R, Peng R, Wang S, Xue C . High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. Onco Targets Ther. 2014; 7:1475-80. PMC: 4149399. DOI: 10.2147/OTT.S61838. View

5.
Chitu V, Stanley E . Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol. 2005; 18(1):39-48. DOI: 10.1016/j.coi.2005.11.006. View